CDK4 and liver cancer: Possible therapies for the overexpressed kinases include CDK4/CDK6 inhibitors, such as Palbociclib, which has been shown effective in human liver cancer cell lines and mouse models with intact tumor suppressor Retinoblastoma (Rb1) (34).